Abstract |
The in vitro elimination of virus-infected and tumor cells by NK cells is regulated by a balance between signals conveyed via specific inhibitory and activating receptors. Whether NK cells and specifically the NK-activating receptor NKp46 (NCR1 in mice) are directly involved in tumor eradication in vivo is still largely unknown. Since the NKp46/NCR1 tumor ligands have not been identified yet, we use a screening technique to identify functional ligands for NKp46/NCR1 which is based on a cell reporter assay and discover a NCR1 ligand in the PD1.6 lymphoma line. To study whether NKp46/NCR1 is important for the eradication of PD1.6 lymphoma in vivo, we used the Ncr1 knockout Ncr1(gfp/gfp) mice generated by our group. Strikingly, all Ncr1 knockout mice developed growing PD1.6 tumors, whereas initial tumor growth was observed in the wild-type mice and tumors were completely rejected as time progressed. The growth of other lymphoma cell lines such as B10 and EL4 was equivalent between the Ncr1 knockout and wild-type mice. Finally, we show that PD1.6 lymphoma cells are less killed both in vitro and in vivo in the absence of NKp46/NCR1. Our results therefore reveal a crucial role for NKp46/NCR1 in the in vivo eradication of some lymphoma cells.
|
Authors | Gili G Halfteck, Moran Elboim, Chamutal Gur, Hagit Achdout, Hormas Ghadially, Ofer Mandelboim |
Journal | Journal of immunology (Baltimore, Md. : 1950)
(J Immunol)
Vol. 182
Issue 4
Pg. 2221-30
(Feb 15 2009)
ISSN: 1550-6606 [Electronic] United States |
PMID | 19201876
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
|
Chemical References |
- Antigens, Ly
- Natural Cytotoxicity Triggering Receptor 1
- Ncr1 protein, mouse
|
Topics |
- Animals
- Antigens, Ly
(genetics, immunology)
- Cytotoxicity, Immunologic
(immunology)
- Flow Cytometry
- In Vitro Techniques
- Killer Cells, Natural
(immunology)
- Lymphoma
(genetics, immunology)
- Mice
- Mice, Knockout
- Natural Cytotoxicity Triggering Receptor 1
(genetics, immunology)
|